Q4 2024 Management View CEO Panna Sharma highlighted 2024 as a transformational year, emphasizing the company's advancements in computational and AI-driven drug discovery, particularly in precision ...

Lantern is a leader in the development of tech-bio to deliver the next generation of cancer medicines, where success is defined by both AI-driven progress and meaningful patient outcomes," said Panna ...

Lantern Pharma (NASDAQ:LTRN – Get Free Report) is expected to be announcing its earnings results before the market opens on ...